Boston Scientific (NYSE:BSX) announced today that it completed its previously announced acquisition of Nalu Medical.
At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.
In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...
Boston University (BU) today announced it has been awarded a $2 million research grant from The Michael J. Fox Foundation for ...